Skip to main content
Premium Trial:

Request an Annual Quote

EdgeBio Receives CLIA Certification, Launches Clinical Exome Test

Premium

EdgeBio has received CLIA certification for its next-generation sequencing operations and has launched a clinical exome test.

The company has been offering next-gen sequencing services and sequencing products since 2008, and currently offers sequencing services on Illumina's HiSeq, Life Technologies' SOLiD 4, and the Ion Torrent PGM.

"For the past three years we have been building expertise in both the generation and analysis of data via NGS in a research setting," CEO Dean Gaalaas said in a statement. "Receiving CLIA certification now allows us to leverage this expertise to help clinicians better diagnose and treat their patients."

EdgeBio joins a number of commercial and academic laboratories offering clinical exome tests, including Ambry Genetics; the University of California, Los Angeles; Washington University's School of Medicine; and Emory University (CSN 3/7/2012, CSN 2/29/2012, CSN 3/21/2012).

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.